PATENT CLAIM ANALYSIS

Application Number: 16007825
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "401000"]

Abstract:
Methods are provided herein for selectively killing senescent cells and for treating senescence-associated diseases and disorders by administering a senolytic agent. Senescence-associated diseases and disorders treatable by the methods using the senolytic agents described herein include cardiovascular diseases and disorders associated with or caused by arteriosclerosis, such as atherosclerosis; idiopathic pulmonary fibrosis; chronic obstructive pulmonary disease; osteoarthritis; senescence-associated ophthalmic diseases and disorders; and senescence-associated dermatological diseases and disorders. Also included herein are methods for extending lifespan.

Claim (Index 11):
The method of  claim 1 , wherein the compound is administered to the test subject twice weekly.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 94.0
- Lexical Diversity: 1.63462
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15981696', '15455684', '15955542', '16007880', '15827539']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8570797382507777
- 35 USC 102 Novelty (BERT): 0.6034259421368247
- Combined Prediction Score: 0.8317143586393824
- Mean Citation Score: 572.9718799999997
- Max Citation Score: 579.3641
- Similarity Product: 463.6427822623253

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test